期刊文献+

吲达帕胺联合缬沙坦治疗老年单纯收缩期高血压146例临床观察

Clinical observation of indapamide valsartan in treatment of treatment of elderly patients with isolated systolic hypertension
原文传递
导出
摘要 目的观察缬沙坦与吲达帕胺联用对老年收缩期高血压的疗效。方法选取老年收缩期高血压病患者146例,给予吲达帕胺2.5mg联合缬沙坦80mg,1次/d。对比治疗前和治疗2周后动态血压的变化。结果本组患者经治疗2周后,患者血压达标率为84.25%,治疗前后比较有显著差异性(P<0.05)。结论吲达帕胺联合缬沙坦对老年收缩期高血压患者有良好的降压作用。 Objective To observe the efficacy of valsartan associated with indapamide for elderly systolic hyperten- sion. Methods Totally 146 elderly systolic hypertension patients: indapamide 2. Smg + valerianlosartan 80mg qd. Ambulatory blood pressure were measured before and after 2 weeks results. Results Two weeks later, the blood pres- sure of 84. 25% patients were up to standardand the result was statistically significant ( P 〈 0. 05 ). Conclusion The in- dapamide united valsartan have good antihypertensive effect to systolic hypertension patients.
出处 《医药论坛杂志》 2013年第11期25-26,共2页 Journal of Medical Forum
关键词 单纯收缩期高血压 缬沙坦 吲达帕胺 Isolated systolic hypertension Valsartan Indapamide
  • 相关文献

参考文献6

二级参考文献33

  • 1全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量:508
  • 2[1]Franklin SS,Khan SA,Wong ND,et al.Is pulse pressure useful in predicting risk for coronary heart disease[J].Circulation,1999,100:354-360.
  • 3[2]Dao HH,Essalihi R,Moreau P,et al.Evolution and modulation of Age-related medial elastocalcinosis:Impact on large artery stiffness and isolated systolic hypertension[J].Cardiovas Res,2005,66:307-317.
  • 4[3]Elliott RJ,McGrath LT.Calcification of the human thoracic aorta during aging[J].Calcif Tissue Int,1994,54:268-273.
  • 5[4]Davies MR,Hruska KA.Pathophysiological mechanisms of vascular calcification in end-stage renal disease[J].Kidney Int,2001,60:472-479.
  • 6[5]Essalihi R,Dao HH,Yamaguchi N,et al.A new model of isolated systolic hypertension induced by chronic warfarin and vitamin k1 treatment[J].Am J Hypertens,2003,16:103-110.
  • 7[6]Guerin AP,London GM,Marchais SJ.Arterial stiffening and vascular calcifications in end-stage renal disease[J].Nephrol Dial Transphlant,2000,15:1014-1021.
  • 8[7]London GM,Guerin AP,Marchais SJ.Arterial media calcification in end-stage renal disease:impact on all-cause and cardiovascular mortality[J].Nephrol Dial Transplant,2003,18:1731-1740.
  • 9[8]Niederhoffer N,Lartaud-Idjouadiene I,Atkinson J.Calcification of medial elastic fibers and aortic elasticity[J].Hypertension,1997,29:999-1006.
  • 10[9]Shao JS,Cai J,Towler DA.Molecular mechanisms of vascular calcification:lessons learned from aorta[J].Arterioscler Thromb Vasc Biol,2006,26:1423-1430.

共引文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部